» Articles » PMID: 11431364

An Intact Overexpressed E-cadherin/alpha,beta-catenin Axis Characterizes the Lymphovascular Emboli of Inflammatory Breast Carcinoma

Overview
Journal Cancer Res
Specialty Oncology
Date 2001 Jun 30
PMID 11431364
Citations 65
Authors
Affiliations
Soon will be listed here.
Abstract

The step of intravasation (lymphovascular invasion), a rate-limiting step in metastasis, is greatly exaggerated in inflammatory breast carcinoma (IBC). Because nearly all human breast carcinoma cell lines grow as solitary nodules in nude/severe combined immunodeficient mice without manifesting lymphovascular invasion, this step has been difficult to study. We captured the essence of the IBC phenotype by establishing a unique human transplantable IBC xenograft, MARY-X, which manifests florid lymphovascular emboli in severe combined immunodeficient/nude mice. Comparing MARY-X with common non-IBC cell lines/xenografts, we discovered an overexpressed and overfunctioning E-cadherin/alpha,beta-catenin axis. In MARY-X, the E-cadherin and catenins were part of a structurally and functionally intact adhesion axis involving the actin cytoskeleton. In vitro, MARY-X grew as round compact spheroids with a cell density 5-10-fold higher than that of other lines. The spheroids of MARY-X completely disadhered when placed in media containing absent Ca(2+) or anti-E-cadherin antibodies or when retrovirally transfected with a dominant-negative E-cadherin mutant (H-2K(d)-E-cad). Anti-E-cadherin antibodies injected i.v. immunolocalized to the pulmonary lymphovascular emboli of MARY-X and caused their dissolution. H-2K(d)-E-cad-transfected MARY-X spheroids were only weakly tumorigenic and did not form lymphovascular emboli. A total of 90% of human IBCs showed increased membrane E-cadherin/alpha,beta-catenin immunoreactivity. These findings indicate that it is the gain and not the loss of the E-cadherin axis that contributes to the IBC phenotype.

Citing Articles

Lymphovascular Tumoral Emboli in Inflammatory Breast Cancer Result from Haptotaxis-Mediated Encircling Lymphangiogenesis.

Wang J, Hoffman R, Ye Y, Dillard J, Barsky S Lymphatics. 2024; 2(4):195-211.

PMID: 39669476 PMC: 11632961. DOI: 10.3390/lymphatics2040016.


Initiation of tumor dormancy by the lymphovascular embolus.

Ye Y, Wang J, Izban M, Ballard B, Barsky S Oncotarget. 2024; 15:726-740.

PMID: 39392391 PMC: 11468568. DOI: 10.18632/oncotarget.28658.


Unique Cohorts of Salivary Gland Cancer Cells as an Model of Circulating Tumor Cells.

Mincy C, Revelt L, Carter K, Reed D, Joy A J Maxillofac Oral Surg. 2024; 23(4):896-908.

PMID: 39118911 PMC: 11303642. DOI: 10.1007/s12663-024-02250-0.


A Novel Preclinical Murine Model to Monitor Inflammatory Breast Cancer Tumor Growth and Lymphovascular Invasion.

Rickard A, Sannareddy D, Bennion A, Patel P, Sauer S, Rouse D Cancers (Basel). 2023; 15(8).

PMID: 37190189 PMC: 10137020. DOI: 10.3390/cancers15082261.


Stabilization of E-cadherin adhesions by COX-2/GSK3β signaling is a targetable pathway in metastatic breast cancer.

Balamurugan K, Poria D, Sehareen S, Krishnamurthy S, Tang W, McKennett L JCI Insight. 2023; 8(6).

PMID: 36757813 PMC: 10070121. DOI: 10.1172/jci.insight.156057.